Integrated Molecular Characterization of Uterine Carcinosarcoma.
about
The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery.New therapies for advanced, recurrent, and metastatic endometrial cancers.Characterization of ascites-derived tumor cells from an endometrial cancer patient.The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing.Trends of uterine carcinosarcoma in the United States.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma.Pan-cancer molecular classes transcending tumor lineage across 32 cancer types, multiple data platforms, and over 10,000 cases.Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.In the literature: April 2017.Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too LatePersonalized Integrated Network Modeling of the Cancer Proteome AtlasEstrogen induces cell proliferation by promoting ABCG2-mediated efflux in endometrial cancer cellsRegulation of PTEN expression by noncoding RNAs
P2860
Q33838714-D546E914-2331-4C63-8FBF-DBEDF42B3CA6Q45395608-C46BEC4D-9DD0-4F89-AE79-1422EA3B9DA7Q46221677-8B7EC3BB-C037-45C5-A5A5-2C617FFF84C7Q47103210-30C88DA9-163D-49A0-B05B-484DC93CFB7EQ47160287-D55D0633-E3D7-4F27-83F0-95C38930AAD7Q47757165-0C7EDDD7-835F-4EB1-81E6-9D162744A0CDQ47970130-DCFDDF7D-9D61-4404-A8BF-B1888211531FQ48107255-A5159613-EAF3-47D6-86D6-0757C0EEA552Q48124146-F7E90C77-0E4C-46B0-81D3-429E567913BBQ49890391-513124E6-1319-42FB-BAD9-8E9C4FA2329CQ50027342-5884491E-1A37-4DE3-9ECB-6707A4268597Q52602405-C8B12916-6B41-4A19-9CC8-85C3281073F2Q52603963-1A3531B8-55A0-4647-987D-307F4F93392FQ55035714-3BCABE04-0B00-424D-80FF-3109AB9A22B6Q57169683-67549934-587A-481A-8C5D-76FD2D1DF031Q57296231-AF32A247-2A57-4506-8C75-339F9394E114Q58119256-B9056AA0-91BA-4B6B-BF5F-BC2D9BA04326Q58754551-2CB34A57-AFE8-4F1D-BA6D-C57C7FE9D3A8
P2860
Integrated Molecular Characterization of Uterine Carcinosarcoma.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Integrated Molecular Characterization of Uterine Carcinosarcoma.
@ast
Integrated Molecular Characterization of Uterine Carcinosarcoma.
@en
Integrated Molecular Characterization of Uterine Carcinosarcoma.
@nl
type
label
Integrated Molecular Characterization of Uterine Carcinosarcoma.
@ast
Integrated Molecular Characterization of Uterine Carcinosarcoma.
@en
Integrated Molecular Characterization of Uterine Carcinosarcoma.
@nl
prefLabel
Integrated Molecular Characterization of Uterine Carcinosarcoma.
@ast
Integrated Molecular Characterization of Uterine Carcinosarcoma.
@en
Integrated Molecular Characterization of Uterine Carcinosarcoma.
@nl
P2093
P2860
P1433
P1476
Integrated Molecular Characterization of Uterine Carcinosarcoma.
@en
P2093
Andrew D Cherniack
Bradley A Murray
Chip Stewart
Douglas A Levine
Gordon B Mills
Gordon Robertson
Jiashan Zhang
John N Weinstein
Peter W Laird
P2860
P304
P356
10.1016/J.CCELL.2017.02.010
P577
2017-03-01T00:00:00Z